肝癌介入治疗后“栓塞后综合征”的预防处理及临床观察  

Clinical observation of treatment and prevention of embolization syndrome after interventional therapy in hepatocellular carcinoma

作　　者：窦浩生[1] 王艳红[1] 高咏梅[1] 

机构地区：[1]山东省临朐县人民医院介入科,山东262600

出　　处：《当代医学》2010年第29期548-549,共2页Contemporary Medicine

摘　　要：目的总结肝癌介入治疗后栓塞后综合征的发生发展规律,探讨其合理治疗原则。方法 763例肝癌病例,介入治疗均操作顺利。结果术后有栓塞后综合征表现者587例,约占76.9%。TACE治疗后表现为局部疼痛者455例、发热者369例、恶心呕吐者576例,分别约占59.6%、48.4%、75.5%。结论栓塞后综合征的预防处理原则是对症处理,全程预防。Objective To explore the occurrence and development of embolization syndrome after interventional treatment.Methods 763 cases of liver cancer received interventional treatment smoothly.Results Embolization syndrome occurred in 587 cases,accounting for 76.9%.After TACE treatment,local pain occurred in 455 cases,fever in 369,nausea and vomiting in 576,accounting for 59.6%,48.4%,75.5% respectively.Conclusion The prevention principles for embolization syndrome are symptomatic treatment and monitor in entire process.

关 键 词：肝癌 TACE 栓塞后综合征 

分 类 号：R735.7[医药卫生—肿瘤]